Covalon Technologies Valuation

CVALF Stock  USD 2.29  0.21  10.10%   
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Covalon Technologies shows a prevailing Real Value of $2.0 per share. The current price of the firm is $2.29. Our model approximates the value of Covalon Technologies from analyzing the firm fundamentals such as Return On Equity of -0.32, profit margin of (0.53) %, and Current Valuation of 35.37 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
2.29
Please note that Covalon Technologies' price fluctuation is very risky at this time. Calculation of the real value of Covalon Technologies is based on 3 months time horizon. Increasing Covalon Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Covalon otc stock is determined by what a typical buyer is willing to pay for full or partial control of Covalon Technologies. Since Covalon Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Covalon OTC Stock. However, Covalon Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.29 Real  2.0 Hype  2.29
The real value of Covalon OTC Stock, also known as its intrinsic value, is the underlying worth of Covalon Technologies OTC Stock, which is reflected in its stock price. It is based on Covalon Technologies' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Covalon Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
2.00
Real Value
5.82
Upside
Estimating the potential upside or downside of Covalon Technologies helps investors to forecast how Covalon otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Covalon Technologies more accurately as focusing exclusively on Covalon Technologies' fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.112.296.11
Details

Covalon Technologies Total Value Analysis

Covalon Technologies is currently expected to have takeover price of 35.37 M with market capitalization of 41.36 M, debt of 2.25 M, and cash on hands of 14.04 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Covalon Technologies fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
35.37 M
41.36 M
2.25 M
14.04 M

Covalon Technologies Investor Information

About 57.0% of the company shares are held by company insiders. The book value of Covalon Technologies was currently reported as 0.96. The company had not issued any dividends in recent years. Covalon Technologies had 1:10 split on the 16th of July 2013. Based on the key indicators related to Covalon Technologies' liquidity, profitability, solvency, and operating efficiency, Covalon Technologies is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.

Covalon Technologies Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Covalon Technologies has an asset utilization ratio of 59.74 percent. This implies that the OTC Stock is making $0.6 for each dollar of assets. An increasing asset utilization means that Covalon Technologies is more efficient with each dollar of assets it utilizes for everyday operations.

Covalon Technologies Ownership Allocation

Covalon Technologies holds a total of 25.07 Million outstanding shares. Covalon Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Covalon Technologies Profitability Analysis

The company reported the revenue of 18.15 M. Net Loss for the year was (9.66 M) with profit before overhead, payroll, taxes, and interest of 7.49 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Covalon Technologies' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Covalon Technologies and how it compares across the competition.

About Covalon Technologies Valuation

The otc valuation mechanism determines Covalon Technologies' current worth on a weekly basis. Our valuation model uses a comparative analysis of Covalon Technologies. We calculate exposure to Covalon Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Covalon Technologies's related companies.
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. Covalon Tech operates under Biotechnology classification in the United States and is traded on OTC Exchange.

8 Steps to conduct Covalon Technologies' Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Covalon Technologies' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Covalon Technologies' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Covalon Technologies' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Covalon Technologies' revenue streams: Identify Covalon Technologies' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Covalon Technologies' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Covalon Technologies' growth potential: Evaluate Covalon Technologies' management, business model, and growth potential.
  • Determine Covalon Technologies' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Covalon Technologies' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Covalon Technologies Growth Indicators

Investing in growth stocks can be very risky. If the company such as Covalon Technologies does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding25.3 M
Quarterly Earnings Growth Y O Y3
Retained Earnings-33.9 M

Complementary Tools for Covalon OTC Stock analysis

When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios